Artelo Biosciences, Inc.
ARTL· Nasdaq
ARTLArtelo Biosciences, Inc.
Source filing unavailable
| Metric | Q3 2021 | Q3 2019 | Q3 2018 | Q3 2017 |
|---|---|---|---|---|
| Net Income | -$2.25M | -$344.88K | -$577.86K | -$96.63K |
| EPS Diluted | — | -$0.40 | -$0.36 | -$0.01 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Artelo Biosciences, Inc. · CIK 1621221 · Engraved from SEC EDGAR
